System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jean-Luc Faucheron is an expert in Surgery at Centre Hospitalier Universitaire de Grenoble (France). As of October 2026, ScienceLeadR ranks Jean-Luc Faucheron in the top 1% of experts worldwide for Rectal Diseases, Colonic Diseases and Intestinal Neoplasms. Jean-Luc Faucheron has authored 298 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 7 of them ongoing. SLR score: 1,196 (community average: 125). How the SLR is computed.

LeadR Profile

Jean-Luc Faucheron Centre Hospitalier Universitaire de Grenoble France
1 196 ScienceLeadR Reputation 1196

Unlock

Register Login
Network Map

Surgery

Subspecialties: Gastroenterology - Oncology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1994 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Grenoble

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 298

Citations

Citations: 7 388 1st author: 76 Last author: 68 Unique author: 7

Main journals

Tech Coloproctol 42
Colorectal Dis 23
Ann Surg 19
Dis Colon Rectum 16
Br J Surg 14

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparison of surgical and oncological outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in upper and middle/lower rectal peritoneal metastases.
PMID 42648158 — cytoreduction surgical procedures, hyperthermia, induced, hyperthermic intraperitoneal chemotherapy, drug therapy, neoplasm metastasis, risk factors, chemotherapy		Surg Oncol20260
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.
PMID 42246495 — urinary tract, neoplasms, recycling, urinary tract infections, rectal neoplasms, risk factors, enhanced recovery after surgery, general surgery, catheterization, infections		Acta Chir Belg20260
Chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer (GRECCAR 15): superiority open-label phase III randomized clinical trial.
PMID 42126061 — neoplasms, drug therapy, re-irradiation, rectal neoplasms, therapeutics, chemotherapy		Br J Surg20260
Colorectal peritoneal metastases treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Should we consider the primary tumour site?
PMID 42061941 — mortality, cytoreduction surgical procedures, hyperthermia, induced, neoplasms, hyperthermic intraperitoneal chemotherapy, colon, drug therapy, neoplasm metastasis, chemotherapy		Surg Oncol20260
Long-Term Bowel Function After Low Anterior Resection with Delayed or Immediate Colo-anal Anastomosis for Rectal Cancer: the ACAQOL Study.
PMID 41989661 — neoplasms, rectal neoplasms		J Gastrointest Cancer20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Director: 3

By phase:

N/A 13
Phase 3 3
Phase 2/Phase 3 2

By status:

Recruiting 8
Completed 7
Unknown 3

By type:

Interventional 10
Observational 8

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 10

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients
NCT06923150 — conservative treatment, gastroenterology, neoplasms, signs and symptoms, rectal neoplasms, therapeutics, low anterior resection syndrome		N/ARecruiting2024
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
NCT06107920 — colostomy, neoplasms, colon, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, colectomy, colonic neoplasms, chemotherapy		Phase 3Recruiting2024
Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)
NCT05233787 — quality of life, neoplasms, enema, sepsis, rectal neoplasms, anastomotic leak, ileostomy		N/ARecruiting2022
Long term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele
NCT05037422 — anesthesia, general, anesthesia, rectocele, retrospective studies, anesthesia, spinal, therapeutics, mucous membrane, spine		N/ARecruiting2021
Recurrence Rate of Hemorrhoidal Disease at 10 Years and More After HAL Doppler or HAL RAR Intervention
NCT04731064 — anesthesia, general, anesthesia, transducers, arteries, rectum, enema, ligation, anesthesia, local, therapeutics, prolapse, needles, surgeons		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS